Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05973955 · ClinicalTrials.gov registry record · NA
Adapting CBT-I for Hazardous Alcohol Users
A NA study of Insomnia and Harmful; Use, Alcohol, sponsored by University of Rochester.
- Recruiting
- Registry status
- NA
- Development phase
- 70
- Enrollment target
- 1
- Study location
NCT05973955: Recruiting NA study of Insomnia and Harmful; Use, Alcohol, sponsored by University of Rochester.
NCT05973955 is a NA study of Insomnia and Harmful; Use, Alcohol that is actively recruiting participants, run by University of Rochester. The registered enrollment target is 70 participants, below the 170-participant average among 151 other Insomnia trials with a reported enrollment target (59% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05973955, a NA study of Insomnia and Harmful; Use, Alcohol, is actively recruiting participants, sponsored by University of Rochester.
- RECRUITING
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this intervention development trial is to develop, refine, and test a telephone-delivered, 4-session version of cognitive behavioral therapy for insomnia adapted to hazardous alcohol users with co-occurring insomnia. The project will begin with a small, open label pilot to refine the intervention and proceed to a small, randomized trial comparing the intervention to a sleep and alcohol education control condition. The two main questions it aims to answer are whether the intervention is feasible to deliver and whether its effects on alcohol use and insomnia severity are large enough to warrant further work.
Primary Outcome
The percentage of days abstinent (PDA) as measured by the Timeline Followback (TLFB)
Conditions Studied
Interventions
- BEHAVIORAL Education Control
- BEHAVIORAL Insomnia Treatment
Study Locations (1)
New York
- University of Rochester Medical Center - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2024-03-22 |
| Est. Completion | 2026-03-31 |
| Phase | NA |
What NCT05973955 shows while recruiting
NCT05973955 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 170-participant average among 151 other Insomnia trials with a reported enrollment target (59% lower).
The record links to 2 conditions, with Insomnia appearing as the primary indexed condition, and to 2 interventions - of which Education Control is the first listed.
NCT05973955 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT05973955 about?
NCT05973955 is a clinical study titled "Adapting CBT-I for Hazardous Alcohol Users". The goal of this intervention development trial is to develop, refine, and test a telephone-delivered, 4-session version of cognitive behavioral therapy for insomnia adapted to hazardous alcohol users with co-occurring insomnia. The project will begin with a small, open label pilot to refine the int...
What is the current status of trial NCT05973955?
This trial is currently recruiting. It is a NA study. The enrollment target is 70 participants. The study started on 2024-03-22. Estimated completion is 2026-03-31.
What conditions does trial NCT05973955 study?
This clinical trial studies the following conditions: Insomnia, Harmful; Use, Alcohol.
What interventions are being tested in trial NCT05973955?
The interventions under investigation include: Education Control (BEHAVIORAL), Insomnia Treatment (BEHAVIORAL).
Who is sponsoring clinical trial NCT05973955?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05973955 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Insomnia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05973955's enrollment target sits among peer trials
70 85th of 151 higher than 65 of 151 other Insomnia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Insomnia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Treatments for Insomnia in Veterans With PTSD
RECRUITING · NA
-
Insomnia Treatment and Cardiometabolic Health in Older Adults With Posttraumatic Stress Disorder
RECRUITING · NA
-
mPATH for Low-income Older Adults
RECRUITING · NA
-
Accelerated Treatment for Co-occurring Insomnia, Nightmares, and PTSD
RECRUITING · NA
-
Adapted CBT-I for Adolescents With Insomnia : The DREAM-IT Study
RECRUITING · NA
-
Treatments in Women Veterans With Insomnia and PTSD
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00969111 · 70 participants · NA
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- NCT01712620 · 70 participants · Phase 2
Spironolactone for Pulmonary Arterial Hypertension
- NCT02143830 · 70 participants · Phase 2
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- NCT02601339 · 70 participants
NIRS Monitoring in Premature Infants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI